Clonal dissemination, emergence of mutator lineages and antibiotic resistance evolution in Pseudomonas aeruginosa cystic fibrosis chronic lung infection.

scientific article

Clonal dissemination, emergence of mutator lineages and antibiotic resistance evolution in Pseudomonas aeruginosa cystic fibrosis chronic lung infection. is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2013PLoSO...871001L
P356DOI10.1371/JOURNAL.PONE.0071001
P932PMC publication ID3741393
P698PubMed publication ID23951065
P5875ResearchGate publication ID255959467

P50authorCarla López-CausapéQ85964688
P2093author name stringAntonio Oliver
Gabriel Cabot
José L Pérez
Xavier Mulet
Bartolomé Moyà
Estrella Rojo-Molinero
Joan Figuerola
Bernat Togores
P2860cites workHypermutability in environmental Pseudomonas aeruginosa and in populations causing pulmonary infection in individuals with cystic fibrosisQ80385327
Sequence variability and functional analysis of MutS of hypermutable Pseudomonas aeruginosa cystic fibrosis isolatesQ82856564
Effect of mutator P. aeruginosa on antibiotic resistance acquisition and respiratory function in cystic fibrosisQ84219534
Bacterial biofilms: a common cause of persistent infectionsQ27861033
The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutantsQ28492576
Role of the multidrug efflux system MexXY in the emergence of moderate resistance to aminoglycosides among Pseudomonas aeruginosa isolates from patients with cystic fibrosisQ28492843
Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typingQ29614699
Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patientsQ29615301
Lung infections associated with cystic fibrosisQ30080000
Impact of Pseudomonas aeruginosa genomic instability on the application of typing methods for chronic cystic fibrosis infectionsQ33909400
Evolution and adaptation in Pseudomonas aeruginosa biofilms driven by mismatch repair system-deficient mutators.Q34082906
Mucoidy, quorum sensing, mismatch repair and antibiotic resistance in Pseudomonas aeruginosa from cystic fibrosis chronic airways infectionsQ34117477
Pseudomonas aeruginosa exhibits frequent recombination, but only a limited association between genotype and ecological setting.Q34412265
Comparison of three molecular techniques for typing Pseudomonas aeruginosa isolates in sputum samples from patients with cystic fibrosisQ34487493
Clinical significance of microbial infection and adaptation in cystic fibrosisQ34491552
Molecular epidemiology of chronic Pseudomonas aeruginosa airway infections in cystic fibrosisQ34500683
High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection.Q34508854
Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: prevalence and impact on resistance in a Spanish multicenter studyQ34932869
Evolutionary dynamics of bacteria in a human host environmentQ34937408
Pathophysiology and Management of Pulmonary Infections in Cystic FibrosisQ35557791
Physical genome analysis of bacteriaQ35573108
Resistance mechanisms of multiresistant Pseudomonas aeruginosa strains from Germany and correlation with hypermutationQ36295397
Efflux unbalance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.Q37190771
Aztreonam lysine: a novel inhalational antibiotic for cystic fibrosisQ37775620
Mutators in cystic fibrosis chronic lung infection: Prevalence, mechanisms, and consequences for antimicrobial therapyQ37788421
Bacterial hypermutation in cystic fibrosis, not only for antibiotic resistanceQ37794342
Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lungQ37799900
Clonal epidemiology of Pseudomonas aeruginosa in cystic fibrosisQ37800566
Intrinsic and environmental mutagenesis drive diversification and persistence of Pseudomonas aeruginosa in chronic lung infectionsQ37955633
Adaptation of Pseudomonas aeruginosa to the cystic fibrosis airway: an evolutionary perspectiveQ38059441
Antagonistic interactions of Pseudomonas aeruginosa antibiotic resistance mechanisms in planktonic but not biofilm growth.Q38626934
Genotypic and phenotypic variation in Pseudomonas aeruginosa reveals signatures of secondary infection and mutator activity in certain cystic fibrosis patients with chronic lung infectionsQ39656697
Efflux pumps, OprD porin, AmpC beta-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.Q40334912
Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa.Q40625683
Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clones.Q41183478
Genetic adaptation of Pseudomonas aeruginosa to the airways of cystic fibrosis patients is catalyzed by hypermutationQ41366386
Population structure and antimicrobial susceptibility of both nonpersistent and persistent Pseudomonas aeruginosa isolates recovered from cystic fibrosis patientsQ41822095
Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammationQ41825397
Wide dispersion of ST175 clone despite high genetic diversity of carbapenem-nonsusceptible Pseudomonas aeruginosa clinical strains in 16 Spanish hospitalsQ41886730
Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infectionsQ41974061
Emergence of a mutL mutation causing multilocus sequence typing-pulsed-field gel electrophoresis discrepancy among Pseudomonas aeruginosa isolates from a cystic fibrosis patient.Q42152337
A cystic fibrosis epidemic strain of Pseudomonas aeruginosa displays enhanced virulence and antimicrobial resistance.Q42604401
Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infectionsQ43593080
Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotypeQ44184795
Role of efflux pumps and mutations in genes for topoisomerases II and IV in fluoroquinolone-resistant Pseudomonas aeruginosa strainsQ44786412
Dynamics of adaptive microevolution of hypermutable Pseudomonas aeruginosa during chronic pulmonary infection in patients with cystic fibrosis.Q46002328
Pulsed-Field Gel ElectrophoresisQ59509098
Pseudomonas aeruginosaMicroevolution during Cystic Fibrosis Lung Infection Establishes Clones with Adapted VirulenceQ61477540
Biological cost of hypermutation in Pseudomonas aeruginosa strains from patients with cystic fibrosisQ61477562
Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosisQ73335181
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue8
P407language of work or nameEnglishQ1860
P921main subjectPseudomonas aeruginosaQ31856
cystic fibrosisQ178194
antibiotic resistanceQ380775
P304page(s)e71001
P577publication date2013-08-12
P1433published inPLOS OneQ564954
P1476titleClonal dissemination, emergence of mutator lineages and antibiotic resistance evolution in Pseudomonas aeruginosa cystic fibrosis chronic lung infection
P478volume8

Reverse relations

cites work (P2860)
Q96303543A Core Genome Multilocus Sequence Typing Scheme for Pseudomonas aeruginosa
Q37552351Advances in understanding Pseudomonas
Q92990527Antibiotic Pollution in the Environment: From Microbial Ecology to Public Policy
Q40559360Antimicrobial Susceptibility of Pseudomonas aeruginosa Isolated from Cystic Fibrosis Patients in Northern Europe.
Q35230652Antimicrobial resistance in the respiratory microbiota of people with cystic fibrosis
Q90050433Comparative Analysis of Peptidoglycans From Pseudomonas aeruginosa Isolates Recovered From Chronic and Acute Infections
Q41787277Draft Genome Sequence of the Quorum-Sensing and Biofilm-Producing Pseudomonas aeruginosa Strain Pae221, Belonging to the Epidemic High-Risk Clone Sequence Type 274.
Q47200948Drug-Driven Phenotypic Convergence Supports Rational Treatment Strategies of Chronic Infections.
Q33911762Evolution of the Pseudomonas aeruginosa mutational resistome in an international Cystic Fibrosis clone
Q42201960Faecal carriage of Pseudomonas aeruginosa in healthy humans: antimicrobial susceptibility and global genetic lineages.
Q40056971Genomics and Susceptibility Profiles of Extensively Drug-Resistant (XDR) Pseudomonas aeruginosa from Spain.
Q51732418Heterogeneous Antimicrobial Susceptibility Characteristics in Pseudomonas aeruginosa Isolates from Cystic Fibrosis Patients.
Q36295260Identification of extensive drug resistant Pseudomonas aeruginosa strains: New clone ST1725 and high-risk clone ST233.
Q40677243N-acetylcysteine selectively antagonizes the activity of imipenem in Pseudomonas aeruginosa by an OprD-mediated mechanism
Q34134267Population structure of clinical Pseudomonas aeruginosa from West and Central African countries
Q64065367Profiling the susceptibility of Pseudomonas aeruginosa strains from acute and chronic infections to cell-wall-targeting immune proteins
Q35975439Pseudomonas aeruginosa AmpR: an acute-chronic switch regulator
Q55497217Pseudomonas aeruginosa Isolates from Spanish Children: Occurrence in Faecal Samples, Antimicrobial Resistance, Virulence, and Molecular Typing.
Q35939649Sequential Treatment of Biofilms with Aztreonam and Tobramycin Is a Novel Strategy for Combating Pseudomonas aeruginosa Chronic Respiratory Infections.
Q40569079Surfactant Protein A Recognizes Outer Membrane Protein OprH on Pseudomonas aeruginosa Isolates From Individuals With Chronic Infection.
Q38300820The problems of antibiotic resistance in cystic fibrosis and solutions
Q35885995The properties of spontaneous mutations in the opportunistic pathogen Pseudomonas aeruginosa
Q42334062VIM-2-Producing Pseudomonas spp. in Uruguay: Sequence Types, Pulsotypes, and Class 1 Integrons Including New Variable Regions Featuring blaVIM-2 and blaGES-7.
Q91647786[Three keys to the appropriate choice of oral antibiotic treatment in the respiratory tract infections]

Search more.